Get the Stockscreener App
5.03
34.25%
-2.62
After Hours:
5.10
0.07
+1.39%
Alvotech stock is traded at $5.03, with a volume of 4.62M.
It is down -34.25% in the last 24 hours and down -39.54% over the past month.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
See More
Previous Close:
$7.65
Open:
$5.81
24h Volume:
4.62M
Relative Volume:
10.16
Market Cap:
$2.38B
Revenue:
$391.87M
Net Income/Loss:
$-441.45M
P/E Ratio:
-2.7189
EPS:
-1.85
Net Cash Flow:
$-301.21M
1W Performance:
-38.13%
1M Performance:
-39.54%
6M Performance:
-38.81%
1Y Performance:
-61.37%
1-Day Range:
$4.81
$5.87
1-Week Range:
$4.81
$8.15
52-Week Range:
$4.81
$13.70
Alvotech Stock (ALVO) Company Profile
Compare ALVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.03 | 2.38B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation Following Recent Share Price Decline - Yahoo! Finance Canada
ALVO Investor ALERT: Block & Leviton Investigating Alvotech for Securities Fraud; Investors ... - Bluefield Daily Telegraph
ALVO Investor ALERT: Block & Leviton Investigating Alvotech - GlobeNewswire
Gold Edges Higher; ISM Manufacturing PMI Falls In October - Benzinga
Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO) - Seeking Alpha
Alvotech Shares Plunge 33% After FDA Flags Issues - Benzinga
Alvotech fell heavily on the Stockholm Stock Exchange, and the OMXS30 index fell 0.4 percent. - MarketScreener
Alvotech drops after US FDA declines to approve arthritis drug - TradingView
Alvotech stock hits 52-week low at 5.82 USD - Investing.com
What technical patterns form on Alvotech (Z45) stock chartsJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
What analysts say about Alvotech Z45 stockSwing Trading Watchlist & Low Investment Wealth Tips - earlytimes.in
Alvotech Shares Slide After FDA Requests Further Action on Simponi Biosimilar - MSN
Applying Wyckoff theory to Alvotech Equity Warrant stockMarket Activity Report & High Accuracy Investment Signals - newser.com
Will Alvotech (Z45) stock rise with strong economy2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
How Alvotech stock performs in high volatility markets2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Alvotech stock falls after FDA issues complete response letter - Investing.com
Alvotech stock falls after FDA issues complete response letter By Investing.com - Investing.com Nigeria
Alvotech Hit By FDA Setback On Key Arthritis Drug - Finimize
Alvotech Equity Warrant stock daily chart insights2025 Fundamental Recap & Technical Buy Zone Confirmations - newser.com
Alvotech falls heavily on the Stockholm Stock Exchange, OMXS30 index rises 0.2 percent - MarketScreener
Alvotech Shares Plunge As FDA Declines To Approve AVT05, A Biosimilar To Simponi - Nasdaq
Is Alvotech stock a smart buy before Fed meetingJuly 2025 Setups & Safe Swing Trade Setup Alerts - newser.com
Alvotech Faces FDA Setback for AVT05 Biosimilar Application - TipRanks
What candlestick patterns are forming on AlvotechTrade Risk Summary & Stepwise Entry and Exit Trade Signals - newser.com
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook - MSN
What the charts say about Alvotech Equity Warrant today2025 Retail Activity & Real-Time Volume Triggers - newser.com
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook (ALVO:NASDAQ) - Seeking Alpha
Applying chart zones and confluence areas to AlvotechWatch List & Stepwise Trade Signal Guides - newser.com
Bittersweet Simponi Verdict For Alvotech As US FDA Knocks Back Golimumab Filing - Citeline News & Insights
Why Alvotech Shares Are Facing Turbulence - TipRanks
Will Alvotech stock benefit from AI adoptionQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Trend analysis for Alvotech this week2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Has Alvotech formed a bullish divergence2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Alvotech (ALVO) Stock: Slips Amid FDA Setback on Simponi Biosimilar AVT05 - parameter.io
Using RSI to spot recovery in Alvotech Equity Warrant2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
News impact scoring models applied to AlvotechJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Will Alvotech continue its uptrendJuly 2025 Selloffs & Accurate Technical Buy Alerts - newser.com
Why Alvotech Equity Warrant stock is considered a top pick2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
How to escape a deep drawdown in AlvotechWeekly Stock Report & High Yield Stock Recommendations - newser.com
Will Alvotech (Z45) stock sustain bullish trend into 2025Weekly Trade Report & Community Shared Stock Ideas - newser.com
Will Alvotech Equity Warrant stock maintain growth storyTreasury Yields & Long-Term Growth Plans - newser.com
Alvotech announces FDA issued CRL for its BLA for AVT05 - TipRanks
Full Stock Market News from 2025-11-02 - Stock Titan
Does Alvotech stock trade at a discount to peersEntry Point & Consistent Growth Equity Picks - newser.com
Predicting Alvotech Equity Warrant trend using moving averages2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05 - The Manila Times
Can Alvotech Equity Warrant stock outperform in 2025 bull marketOptions Play & Entry Point Confirmation Alerts - newser.com
Alvotech Receives Complete Response Letter from FDA for Biosimilar AVT05 Application - Quiver Quantitative
Alvotech SA revises 2025 revenue outlook to $570-$600 million - MarketScreener
Alvotech (NASDAQ: ALVO) updates revenue outlook to $570-$600M after FDA CRL - Stock Titan
Visual trend scoring systems applied to Alvotech Equity WarrantBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):